For NT-proBNP, HR associations (for breast, prostate, and colorectal cancer) were of moderate magnitude, with highest hazard ratio of 2.2 for top vs. bottom quartiles (colorectal cancer), and for this biomarker there was no change in HR estimates after additional covariate adjustments. This evidence concerns the gene NPPB and colorectal cancer.